In particular, the first reports of genetic contributions to PAH were identified by linkage studies in which mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) were found in approximately 75% of cases of HPAH and in about 20% of patients with IPAH3–6. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.